LivaNova PLC: LivaNova Launches SenTiva DUO
New device expands access to the latest technology for legacy VNS Therapy patients with drug-resistant epilepsy in the U.S. LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation
Source: finanznachrichten.de